Illustrations of inhaled anesthetic uptake, including intertissue diffusion to and from fat

Anesthesia and Analgesia

Volumn 100, Issue 4, 2005, Pages 1020-1033

  Eger II, Edmond I ^a,c   Saidman, Lawrence J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESFLURANE; ENFLURANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; PROPOFOL; SEVOFLURANE;

ANESTHETIC RECOVERY; BLOOD FLOW; BODY FAT; COMPUTER SIMULATION; DRUG DIFFUSION; DRUG SOLUBILITY; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; LUNG VENTILATION; OBESITY; PRIORITY JOURNAL; REVIEW; TISSUE;

ADIPOSE TISSUE; ALGORITHMS; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, INHALATION; ANIMALS; DIFFUSION; HUMANS; OBESITY; PULMONARY ALVEOLI;

EID: 15544380040     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000146961.70058.A1     Document Type: Review

References (81)

1. Eger EI II, Saidman LJ. Anesthetic uptake at a constant alveolar concentration. In: Clinical anesthesia. Vol 3. Philadelphia: FA Davis, 1964:35-53.
2. Eger EI II, Guadagni NP. Halothane uptake in man at constant alveolar concentration. Anesthesiology 1963;24:299-304.
3. Carpenter RL, Eger EI II, Johnson BH, et al. Pharmacokinetics of inhaled anesthetics in humans: measurements during and after the simultaneous administration of enflurane, halothane, isoflurane, methoxyflurane, and nitrous oxide. Anesth Analg 1986;65: 575-82.
4. Carpenter RL, Eger EI II, Johnson BH, et al. The extent of metabolism of inhaled anesthetics in humans. Anesthesiology 1986;65:201-5.
5. Carpenter RL, Eger EI II, Johnson BH, et al. Does the duration of anesthetic administration affect the pharmacokinetics or metabolism of inhaled anesthetics in humans? Anesth Analg 1987;66: 1-8.
6. Yasuda N, Lockhart SH, Eger EI II, et al. Kinetics of desflurane, isoflurane, and halothane in humans. Anesthesiology 1991;74: 489-98.
7. Yasuda N, Lockhart SH, Eger EI II, et al. Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth Analg 1991; 72:316-24.
8. Allott PR, Steward A, Mapleson WW. Pharmacokinetics of halothane in the dog: comparison of theory and measurement in individuals. Br J Anaesth 1976;48:279-95.
9. Perl W, Rackow H, Salanitre S, et al. Intertissue diffusion effect for inert fat-soluble gases. J Appl Physiol 1965;20:621-7.
10. Cohen EN, Chow KL, Mathers L. Autoradiographic distribution of volatile anesthetics within the brain. Anesthesiology 1972;37: 324-31.
11. Stanley TH, Kawamura R, Graves C. Effects of nitrous oxide on volume and pressure of endotracheal tube cuffs. Anesthesiology 1974;41:256-62.
12. Algren JT, Gursoy F, Johnson TD, Skjonsby BS. The effect of nitrous oxide diffusion on laryngeal mask airway cuff inflation in children. Paediatr Anaesth 1998;8:31-6.
13. Eisenkraft JB, Eger EI II. Nitrous oxide anesthesia may double the balloon gas volume of Swan-Ganz catheters. Mt Sinai J Med 1982;49:430-3.
14. Brimacombe J, Berry A. Laryngeal mask airway cuff pressure and position: the effect of adding nitrous oxide to the cuff. Anesthesiology 1994;80:957-8.
15. Kaur S, Cortiella J, Vacanti CA. Diffusion of nitrous oxide into the pleural cavity. Br J Anaesth 2001;87:894-6.
16. Lockhart SH, Yasuda Y, Peterson N, et al. Comparison of percutaneous losses of sevoflurane and isoflurane in humans. Anesth Analg 1991;72:212-5.
17. Fassoulaki A, Lockhart S, Freire BA, et al. Percutaneous loss of desflurane, isoflurane and halothane in humans. Anesthesiology 1991;74:479-83.
18. Laster MJ, Tahari S, Eger EI II, et al. Visceral losses of desflurane, isoflurane, and halothane in swine. Anesth Analg 1991;73: 209-12.
19. Eger EI II, Johnson BH. Rates of awakening from anesthesia with I-653, halothane, isoflurane, and sevoflurane: a test of the effect of anesthetic concentration and duration in rats. Anesth Analg 1987;66:977-82.
20. Eger EI II, Gong D, Koblin DD, et al. Effect of anesthetic duration on kinetic and recovery characteristics of desflurane vs. sevoflurane (plus compound A) in volunteers. Anesth Analg 1998;86:414-21.
21. Munson ES, Eger EI II, Bowers DL. Effects of anesthetic-depressed ventilation and cardiac output on anesthetic uptake. Anesthesiology 1973;38:251-9.
22. Eger EI II, Severinghaus JW. Effect of uneven pulmonary distribution of blood and gas on induction with inhalation anesthetics. Anesthesiology 1964;25:620-6.
23. Strum DP, Eger EI II, Unadkat JD, et al. Age affects the pharmacokinetics of inhaled anesthetics in humans. Anesth Analg 1991;73:310-8.
24. Eger EI II, Bahlman SH, Munson ES. Effect of age on the rate of increase of alveolar anesthetic concentration. Anesthesiology 1971;35:365-72.
25. Lerman J, Schmitt-Bantel BI, Gregory GA, et al. Effect of age on the solubility of volatile anesthetics in human tissues. Anesthesiology 1986;65:307-11.
26. Wyatt HR. The prevalence of obesity. Prim Care 2003;30:267-79.
27. Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we go from here? Science 2003;299: 853-5.
28. Adams JP, Murphy PG. Obesity in anaesthesia and intensive care. Br J Anaesth 2000;85:91-108.
29. Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999; 282:1519-22.
30. Auler JO Jr, Miyoshi E, Fernandes CR, et al. The effects of abdominal opening on respiratory mechanics during general anesthesia in normal and morbidly obese patients: a comparative study. Anesth Analg 2002;94:741-8.
31. Eichenberger A, Proietti S, Wicky S, et al. Morbid obesity and postoperative pulmonary atelectasis: an underestimated problem. Anesth Analg 2002;95:1788-92.
32. Hood EE, Dewan DM. Anesthetic and obstetric outcome in morbidly obese parturients. Anesthesiology 1993;79:1210-8.
33. Bentley JB, Vaughan RW, Gandolfi AJ, Cork RC. Halothane biotransformation in obese and non-obese patients. Anesthesiology 1982;57:94-7.
34. Bentley JB, Vaughan RW, Miller MS, et al. Serum inorganic fluoride levels in obese patients during and after enflurane anesthesia. Anesth Analg 1979;58:409-12.
35. Frink EJ Jr, Malan TP Jr, Brown E, et al. Plasma inorganic fluoride levels with sevoflurane anesthesia in morbidly obese and nonobese patients. Anesth Analg 1993;76:1333-7.
36. Ogunnaike BO, Jones SB, Jones DB, et al. Anesthetic considerations for bariatric surgery. Anesth Analg 2002;95:1793-805.
37. Damia G, Mascheroni D, Croci M, Tarenzi L. Perioperative changes in functional residual capacity in morbidly obese patients. Br J Anaesth 1988;60:574-8.
38. Alpert MA, Hashimi VW. Obesity and the heart. Am J Med Sci 1989;306:117-23.
39. Dwyer R, Bennett HL, Eger EI II, Heilbron D. Effects of isoflurane and nitrous oxide in subanesthetic concentrations on memory and responsiveness in volunteers. Anesthesiology 1992;77: 888-98.
40. Chortkoff BS, Gonsowski CT, Bennett HL, et al. Subanesthetic concentrations of desflurane and propofol suppress recall of emotionally charged information. Anesth Analg 1995;81:728-36.
41. Katoh T, Suguro Y, Ikeda T, et al. Influence of age on awakening concentrations of sevoflurane and isoflurane. Anesth Analg 1993;76:348-52.
42. Severinghaus JW. Role of lung factors. In: Papper E, Kitz R, eds. Uptake and distribution of anesthetic agents. New York: McGraw-Hill, 1963:59-71.
43. Juvin P, Vadam C, Malek L, et al. Postoperative recovery after desflurane, propofol, or isoflurane anesthesia among morbidly obese patients: a prospective, randomized study. Anesth Analg 2000;91:714-9.
44. De Baerdemaeker LEC, Struys MMRF, Jacobs S, et al. Optimization of desflurane administration in morbidly obese patients: a comparison with sevoflurane using an 'inhalation bolus' technique. Br J Anaesth 2003;91:638-50.
45. Torri G, Casati A, Comotti L, et al. Wash-in and wash-out curves of sevoflurane and isoflurane in morbidly obese patients. Minerva Anestesiol 2002;68:523-7.
46. Torri G, Casati A, Albertin A, et al. Randomized comparison of isoflurane and sevoflurane for laparoscopic gastric banding in morbidly obese patients. J Clin Anesth 2001;13:565-70.
47. Sollazzi L, Perilli V, Modesti C, et al. Volatile anesthesia in bariatric surgery. Obes Surg 2001;11:623-6.
48. Hanks EC, Ngai SH, Fink R. The respiratory threshold for carbon dioxide in anesthetized man. Anesthesiology 1961;22: 393-7.
49. Lambertsen CJ, Kough RH, Cooper DY, et al. Oxygen toxicity: effects in man of oxygen inhalation at 1 and 3.5 atmospheres upon blood gas transport, cerebral circulation and cerebral metabolism. J Appl Physiol 1953;5:471-86.
50. Sasano H, Vesely AE, Iscoe S, et al. A simple apparatus for accelerating recovery from inhaled volatile anesthetics. Anesth Analg 2001;93:1188-91.
51. Vesely A, Fisher JA, Sasano N, et al. Isocapnic hyperpnoea accelerates recovery from isoflurane anaesthesia. Br J Anaesth 2003;91:787-92.
52. Eger EI II. Desflurane (Suprane): a compendium and reference. Rutherford, NJ: Healthpress Publishing Group, 1993:1-119.
53. Siebeck R. Uber die Aufnahme von Stickoxydul in Blut. Skand Arch Physiol 1909;21:368-82.
54. Saidman LJ, Eger EI II, Munson ES, Severinghaus JW. A method for determining solubility of anesthetics utilizing the Scholander apparatus. Anesthesiology 1966;27:180-4.
55. Orcutt FS, Seevers MH. A method for determining the solubility of gases in pure liquids or solutions using the Van Slyke-Neill manometric apparatus. J Biol Chem 1937;117:501-7.
56. Cullen SC, Cook EV. Solubility of nitrous oxide in human blood. J Biol Chem 1943;147:23-6.
57. Ostiguy GL, Becklake MR. Solubility of nitrous oxide in human blood. J Appl Physiol 1966;21:1397-9.
58. Gibbs CP, Munson ES, Tham MK. Anesthetic solubility coefficients for maternal and fetal blood. Anesthesiology 1975;43: 100-3.
59. Kety SS, Harmel MH, Broomell HT, Rhode CB. Solubility of nitrous oxide in blood and brain. J Biol Chem 1948;173:487-96.
60. Eger EI II. Partition coefficients of I-653 in human blood, saline, and olive oil. Anesth Analg 1987;66:971-3.
61. Lockwood GG, Sapsed-Byrne SM, Smith MA. Effect of temperature on the solubility of desflurane, sevoflurane, enflurane and halothane in blood. Br J Anaesth 1997;79:517-20.
62. Strum DP, Eger EI II. Partition coefficients for sevoflurane in human blood, saline, and olive oil. Anesth Analg 1987;66:654-6.
63. Malviya S, Lerman J. The blood/gas solubilities of sevoflurane, isoflurane, halothane, and serum constituent concentrations in neonates and adults. Anesthesiology 1990;72:793-6.
64. Lerman J, Gregory GA, Eger EI II. Hematocrit and the solubility of volatile anesthetics in blood. Anesth Analg 1984;63:911-4.
65. Cromwell TH, Eger EI II, Stevens WC, Dolan WM. Forane uptake, excretion and blood solubility in man. Anesthesiology 1971;35:401-8.
66. Eger RR, Eger EI II. Effect of temperature and age on the solubility of enflurane, halothane, isoflurane and methoxyflurane in human blood. Anesth Analg 1985;64:640-2.
67. Larson CP Jr, Eger EI II, Severinghaus JW. The solubility of halothane in blood and tissue homogenates. Anesthesiology 1962;23:349-55.
68. Yasuda N, Targ AG, Eger EI II. Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues. Anesth Analg 1989; 69:370-3.
69. Zhou J-X, Liu J. The effect of temperature on solubility of volatile anesthetics in human tissues. Anesth Analg 2001;93:234-8.
70. Kozam RL, Landau SM, Cubina JM, Lukas DS. Solubility of nitrous oxide in biologic fluid and myocardium. J Appl Physiol 1970;29:593-7.
71. Assali NS, Ross M. Nitrous oxide solubility in fetal and uterine tissues in human pregnancy. Proc Soc Exp Biol 1959;100:497-8.
72. Gabel RA, Schultz B. Solubility of nitrous oxide in water, 20-80 C. Anesthesiology 1973;38:75-81.
73. Shim JC, Kaminoh Y, Tashiro C, et al. Solubility of volatile anesthetics in plasma substitutes, albumin, intravenous fat emulsions, perfluorochemical emulsion, and aqueous solutions. J Anesth 1996;10:276-81.
74. Firestone LL, Miller JC, Miller KW. Tables of physical and pharmacological properties of anesthetics. In: Roth SH, Miller KW, eds. Molecular and cellular mechanisms of anesthetics. New York: Plenum Medical Book Co, 1986:455-70.
75. Lerman J, Willis MM, Gregory GA, Eger EI II. Osmolarity determines the solubility of anesthetics in aqueous solutions at 37°C. Anesthesiology 1983;59:554-8.
76. Smith RA, Porter EG, Miller KW. The solubility of anesthetic gases in lipid bilayers. Biochim Biophys Acta 1981;645:327-38.
77. Honemann CW, Washington J, Honemann MC, et al. Partition coefficients of volatile anesthetics in aqueous electrolyte solutions at various temperatures. Anesthesiology 1998;89:1032-5.
78. Frohlich D, Rothe G, Schwall B, et al. Effects of volatile anaesthetics on human neutrophil oxidative response to the bacterial peptide FMLP. Br J Anaesth 1997;78:718-23.
79. Renzi F, Waud BE. Partition coefficients of volatile anesthetics in Krebs' solution. Anesthesiology 1977;47:62-3.
80. Halliday MM, MacDonald I, MacGregor MHG. Gas Chromatographic determination of Ostwald solubility coefficients for cyclopropane, halothane and trichloroethane (trichloroethylene). Br J Anaesth 1977;49:413-7.
81. Meyer KH, Gottlieb-Billroth H. Theorie der Narkose durch Inhalationsanästhetika. Z Physiol Chem 1920;112:55-79.